Blueprint Medicines Corp Business Finance Contracts & Agreements
18 Contracts & Agreements
- Financing Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (2)
- Purchase Agreements (2)
- Release Agreements (1)
- Stock Agreements (3)
- Underwriting Agreements (6)
- Warrant Agreements (2)
- First Amendment to Financing Agreement dated as of May 22, 2023 by and among Blueprint Medicines Corporation, the lenders party thereto, and TAO Talents LLC, as Administrative... (Filed With SEC on May 25, 2023)
- Non-Qualified Stock Option for Employees under the 2020 Inducement Plan (Filed With SEC on February 16, 2023)
- Purchase and Sale Agreement, dated as of June 30, 2022, by and among the Registrant Garnich Adjacent Investments S.a.r.l. the various other purchasers from time to time party... (Filed With SEC on August 2, 2022)
- Purchase and Sale Agreement, dated as of June 30, 2022, by and between the Registrant and Royalty Pharma Investments 2019 ICAV (Filed With SEC on August 2, 2022)
- 2015 Employee Stock Purchase Plan (Filed With SEC on February 13, 2020)
- Underwriting Agreement, dated as of January 22, 2020, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on January 23, 2020)
- Underwriting Agreement, dated as of March 28, 2019, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on March 29, 2019)
- Underwriting Agreement, dated as of December 12, 2017, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the... (Filed With SEC on December 13, 2017)
- Blueprint Medicines Corporation Common Stock, $0.001 par value Underwriting Agreement (Filed With SEC on March 30, 2017)
- Blueprint Medicines Corporation Common Stock, $0.001 par value Underwriting Agreement (Filed With SEC on December 8, 2016)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 11, 2016)
- Blueprint Medicines Corporation Common Stock, $0.001 par value Underwriting Agreement (Filed With SEC on April 10, 2015)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 23, 2015)
- [FORM OF] RELEASE AGREEMENT (Filed With SEC on March 23, 2015)
- BLUEPRINT MEDICINES CORPORATION AMENDMENT NO. 1 TO 2011 STOCK OPTION AND GRANT PLAN (Filed With SEC on March 23, 2015)
- BLUEPRINT MEDICINES CORPORATION SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on March 23, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on March 23, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on March 23, 2015)
